Miguel Ángel Ulloa-Miranda, E. Sánchez-Forgach, Fernando Sánchez-Aguirre, Marcelino Hernández-Valencia, D. I. Hernández-Hernández, Miriam Rosas-Luna, Julio Ignacio Ramírez-Gómez
{"title":"Incidencia de mutaciones genéticas en pacientes con cáncer de mama y ovario con patrón de origen hereditario","authors":"Miguel Ángel Ulloa-Miranda, E. Sánchez-Forgach, Fernando Sánchez-Aguirre, Marcelino Hernández-Valencia, D. I. Hernández-Hernández, Miriam Rosas-Luna, Julio Ignacio Ramírez-Gómez","doi":"10.24245/gom.v88i2.3427","DOIUrl":null,"url":null,"abstract":"OBJECTIVE: To determine the genetic mutations in hereditary pattern breast cancer and demonstrate whether there is a significant association between the most common in the Mexican population and the risk of suffering it. MATERIALS AND METHODS: Cross-sectional and observational study conducted at the Hospital Angeles México in coordination with the National Institute of Genomic Medicine. Inclusion criteria: patients with breast cancer and one or more first-degree relatives affected by this disease and patients with ovarian cancer. Exclusion criteria: patients without a history of breast or ovarian cancer, or with a family member in the protocol. The RT2 Profiler plate rearrangement technique was used for Master-Mix Quantinova probe PCR kit. The SPSS version 22 program and Epi Info version 7 were used for the statistical analysis. RESULTS: 39 patients with an average age of 53.2 ± 12.1 years were studied. Pro- gesterone and estrogen receptors showed no difference between groups. There was a statistical difference, and CONCLUSION: The data obtained show that in the Mexican population the BRCA2 has a higher incidence in hereditary cancer, at an age of earlier onset and greater nuclear grade at the time of diagnosis.","PeriodicalId":12654,"journal":{"name":"Ginecologia y obstetricia de Mexico","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ginecologia y obstetricia de Mexico","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24245/gom.v88i2.3427","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
OBJECTIVE: To determine the genetic mutations in hereditary pattern breast cancer and demonstrate whether there is a significant association between the most common in the Mexican population and the risk of suffering it. MATERIALS AND METHODS: Cross-sectional and observational study conducted at the Hospital Angeles México in coordination with the National Institute of Genomic Medicine. Inclusion criteria: patients with breast cancer and one or more first-degree relatives affected by this disease and patients with ovarian cancer. Exclusion criteria: patients without a history of breast or ovarian cancer, or with a family member in the protocol. The RT2 Profiler plate rearrangement technique was used for Master-Mix Quantinova probe PCR kit. The SPSS version 22 program and Epi Info version 7 were used for the statistical analysis. RESULTS: 39 patients with an average age of 53.2 ± 12.1 years were studied. Pro- gesterone and estrogen receptors showed no difference between groups. There was a statistical difference, and CONCLUSION: The data obtained show that in the Mexican population the BRCA2 has a higher incidence in hereditary cancer, at an age of earlier onset and greater nuclear grade at the time of diagnosis.